
Legal20 Jun 2026, 07:20 pm
Medplus Subsidiary's Drug License Suspended for 10 Days in Maharashtra
AI Summary
Medplus Health Services Ltd announced that its subsidiary, Optival Health Solutions Private Limited, has received a suspension order for a drug license for a store located in Maharashtra. The suspension is for a period of 10 days, effective from June 20, 2026. This action was taken by the Asst. Commissioner & Licensing authority, Food & Drug Administration, MH, Pune, citing violations under the Drugs and Cosmetics Act, 1940 and Rules, 1945. The company estimates a potential revenue loss of ₹2.68 lacs due to this suspension. The details of the order will be available on the company's website and stock exchange websites.
Key Highlights
- Subsidiary's drug license suspended for 10 days in Maharashtra.
- Potential revenue loss estimated at ₹2.68 lacs.
- Action taken by Food & Drug Administration, Pune.
- Violation cited under Drugs and Cosmetics Act, 1940.
Price Impact
More from MEDPLUS